BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34571093)

  • 1. Comparing the outcomes of intrapleural fibrinolytic and DNase therapy versus intrapleural fibrinolytic or DNase therapy: A systematic review and meta-analysis.
    Chong WH; Hu K; Saha BK; Chopra A
    Pulm Pharmacol Ther; 2021 Dec; 71():102081. PubMed ID: 34571093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.
    Altmann ES; Crossingham I; Wilson S; Davies HR
    Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choice of intrapleural fibrinolytic agents in the treatment of adult complicated parapneumonic effusion and empyema: Network meta-analysis.
    Yokoyama Y; Kuno T; Takagi H; Burfeind W
    Asian Cardiovasc Thorac Ann; 2023 Jun; 31(5):451-458. PubMed ID: 37287257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of Intrapleural Tissue Plasminogen Activator and Dornase Alfa vs Tissue Plasminogen Activator Alone in Children with Pleural Empyema: A Randomized Clinical Trial.
    Livingston MH; Mahant S; Connolly B; MacLusky I; Laberge S; Giglia L; Yang C; Roberts A; Shawyer A; Brindle M; Parsons S; Stoian C; Walton JM; Thorpe KE; Chen Y; Zuo F; Mamdani M; Chan C; Loong D; Isaranuwatchai W; Ratjen F; Cohen E
    JAMA Pediatr; 2020 Apr; 174(4):332-340. PubMed ID: 32011642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials.
    Nie W; Liu Y; Ye J; Shi L; Shao F; Ying K; Zhang R
    Clin Respir J; 2014 Jul; 8(3):281-91. PubMed ID: 24428897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Variables for Failure in Administration of Intrapleural Tissue Plasminogen Activator/Deoxyribonuclease in Patients With Complicated Parapneumonic Effusions/Empyema.
    Khemasuwan D; Sorensen J; Griffin DC
    Chest; 2018 Sep; 154(3):550-556. PubMed ID: 29425674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema.
    Cameron R; Davies HR
    Cochrane Database Syst Rev; 2008 Apr; (2):CD002312. PubMed ID: 18425881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema.
    Cameron R; Davies HR
    Cochrane Database Syst Rev; 2004; (2):CD002312. PubMed ID: 15106174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Tissue Plasminogen Activator and DNase for Complicated Pleural Effusions Secondary to Abdominal Pathology.
    Majid A; Ochoa S; Chatterji S; Fernandez-Bussy S; Kheir F; Rivera E; Cheng G; Folch E
    Ann Am Thorac Soc; 2017 Mar; 14(3):342-346. PubMed ID: 28079399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New strategies to manage complicated pleural effusions.
    Safiyeh M; Huang D
    Crit Care; 2012 May; 16(3):312. PubMed ID: 22621656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-pleural fibrinolytic therapy vs. conservative management in the treatment of parapneumonic effusions and empyema.
    Cameron R
    Cochrane Database Syst Rev; 2000; (3):CD002312. PubMed ID: 10908554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrapleural use of tissue plasminogen activator and DNase in pleural infection.
    Rahman NM; Maskell NA; West A; Teoh R; Arnold A; Mackinlay C; Peckham D; Davies CW; Ali N; Kinnear W; Bentley A; Kahan BC; Wrightson JM; Davies HE; Hooper CE; Lee YC; Hedley EL; Crosthwaite N; Choo L; Helm EJ; Gleeson FV; Nunn AJ; Davies RJ
    N Engl J Med; 2011 Aug; 365(6):518-26. PubMed ID: 21830966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions: a meta-analysis.
    Tokuda Y; Matsushima D; Stein GH; Miyagi S
    Chest; 2006 Mar; 129(3):783-90. PubMed ID: 16537882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Intrapleural Sepsis with Once Daily Use of Tissue Plasminogen Activator and Deoxyribonuclease.
    Mehta HJ; Biswas A; Penley AM; Cope J; Barnes M; Jantz MA
    Respiration; 2016; 91(2):101-6. PubMed ID: 26761711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrapleural Fibrinolytics and Deoxyribonuclease for Treatment of Indwelling Pleural Catheter-Related Pleural Infection: A Multi-Center Observational Study.
    Fitzgerald DB; Muruganandan S; Tsim S; Ip H; Asciak R; Walker S; Uribe Becerra JP; Majid A; Ahmed L; Rahman NM; Maskell NA; Blyth KG; Lee YCG
    Respiration; 2021; 100(5):452-460. PubMed ID: 33784710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination Tissue Plasminogen Activator and DNase for Loculated Malignant Pleural Effusions: A Single-center Retrospective Review.
    Chan C; Sekowski V; Zheng B; Li P; Stollery D; Veenstra J; Gillson AM
    J Bronchology Interv Pulmonol; 2023 Jul; 30(3):238-243. PubMed ID: 35698287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery.
    Piccolo F; Pitman N; Bhatnagar R; Popowicz N; Smith NA; Brockway B; Nickels R; Burke AJ; Wong CA; McCartney R; Choo-Kang B; Blyth KG; Maskell NA; Lee YC
    Ann Am Thorac Soc; 2014 Nov; 11(9):1419-25. PubMed ID: 25296241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteplase Dose Assessment for Pleural infection Therapy (ADAPT) Study-2: Use of 2.5 mg alteplase as a starting intrapleural dose.
    Popowicz N; Ip H; Lau EPM; Piccolo F; Dootson K; Yeoh C; Phu WY; Brown R; West A; Ahmed L; Lee YCG
    Respirology; 2022 Jul; 27(7):510-516. PubMed ID: 35441458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrapleural agents for pleural infection: fibrinolytics and beyond.
    Rahman NM
    Curr Opin Pulm Med; 2012 Jul; 18(4):326-32. PubMed ID: 22487944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current value of intrapleural fibrinolysis in the treatment of exudative fibrinous pleural effusions in pleural empyema and hemothorax].
    Kemper P; Köhler D
    Pneumologie; 1999 Aug; 53(8):373-84. PubMed ID: 10483276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.